Related Experiment Video
Updated: Jan 20, 2026

Subjective Refraction Test Using a Smartphone for Vision Screening
Published on: October 18, 2024
As-indicated versus routine vision screening of preterm children: a 17-year retrospective regional study
Lotte Welinder1, Lars Bender2, Helle Højmark Eriksen3
1Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark.
Insights
Routine vision screening for preterm infants did not identify more cases of visual impairment compared to as-needed eye exams. This suggests that current screening protocols for retinopathy of prematurity (ROP) may be sufficient.
Area of Science:
- Ophthalmology
- Neonatal Care
- Public Health
Background:
- Preterm infants are at higher risk for visual impairments, including retinopathy of prematurity (ROP).
- Effective screening strategies are crucial for early detection and intervention in this vulnerable population.
Purpose of the Study:
- To compare the outcomes of routine, scheduled vision screening versus as-indicated ophthalmological investigations for preterm infants.
- To evaluate the effectiveness of different screening approaches in identifying visual impairments in preterm children.
Main Methods:
- A retrospective study comparing two groups of preterm infants (born <32 weeks gestation or <1500g) in Denmark (1997-2014).
- The 'as-indicated' group (1997-2009) received investigations only if treated for ROP or referred for visual issues.
- The 'screening' group (2010-2014) received scheduled ophthalmological investigations at 6 months and 3 years.
Main Results:
- No significant difference in the proportion of children with visual acuity <6/18 at 3 years between the as-indicated (2.7%) and screening (3.5%) groups (p=0.24).
- Cerebral palsy and epilepsy were significantly associated with vision impairment (p<0.01), but treated ROP was not.
- Refractive errors, particularly astigmatism, were common at 3 years (61%), but not associated with gestational age, birthweight, or ROP history.
Conclusions:
- Scheduled vision screening at 6 months and 3 years for preterm infants did not detect more visually impaired children than an as-indicated approach.
- The findings suggest that current screening protocols for retinopathy of prematurity may be adequate in identifying visual impairments in preterm populations.
Purpose:
To investigate outcomes of routine vision screening compared to as-indicated ophthalmological investigation of all children born preterm in a Danish region from 1997 to 2014.
Methods:
All children born preterm (gestation age < 32 weeks or birthweight < 1500 g) screened for retinopathy of prematurity (ROP) were divided into two groups. From 1997 to 2009, only children treated for ROP or referred for visual problems received ophthalmological investigation (as-indicated group). From 2010 to 2014, all ROP-screened infants were offered ophthalmological investigation at 6 months and 3 years of age (screening group).
Results:
A total of 560 children were included in the as-indicated period, 41 and 87 were referred for ophthalmological investigation at 6 months and 3 years, respectively. In the screening period, 295 children were included, 251 and 150 of whom underwent vision evaluation at 6 months and 3 years, respectively. Mean visual acuity was 4.1 cycles per degree with Teller acuity cards at 6 months and 0.78 decimal at 3 years. At 3 years, 2.7%(n = 11) in the as-indicated versus 3.5%(n = 10) screening group had visual acuity < 6/18 (p = 0.24). Cerebral palsy (n = 28) and epilepsy (n = 5) were significantly related to vision impairment (p = 0.001/0.006), while treated ROP was not (n = 13). Refractive error was common at 3 years (61%), especially astigmatism (50%). Gestational age, birthweight and ROP were not associated with vision impairment or refractive error.
Conclusion:
Screening preterm children at 6 months and 3 years did not reveal more visually impaired children compared to examination when indicated.
Related Concept Videos
Vision
Color Vision
IR Frequency Region: Fingerprint Region
Depth Perception and Spatial Vision
The Eukaryotic Promoter Region
Region of Convergence

